Tzield Injection
Product Images NDC 73650-316

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tzield (NDC 73650-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Provention Bio, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Carton (Principal Panel)

This is a medication labeled as Tzield (teplizumab-mzwv) which is administered through injection. It contains 2mg/2mL (1mg/mL) in a single dose vial, and the unused portion should be discarded. It is only available with a prescription and has an NDC number of 73650-316-01. The label also mentions a company called Lroventionbio.*

FDA Label Image

Image Of Carton (Principal Panel)

Tzield is a medication available in injection form with the active ingredient teplizumab-mzwv. It is provided in single-dose vials with a concentration of 2mg/2mL. The medication guide should be given to each patient and any unused portion should be discarded. It is intended for intravenous infusion after dilation and should be stored in the original carton in a protected area. The brand or company name Reonly is also mentioned.*

FDA Label Image

Image Of Carton (Principal Panel)

Tzield is a medication that comes in injection form with a concentration of 2mg/2mL (1 mg/mL). Each carton contains 14 single dose vials, and any unused portion should be discarded. It is meant for intravenous infusion after dilution and comes with an original carton to protect it. The medication has received NOC T3650-36-14.*

FDA Label Image

Image Of Figure 1 (Fig 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.